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Abstract 
It remains unclear how readiness for Ca2+-dependent exocytosis depends on varying 
degrees of SNARE complex assembly. Here I directly investigate the SNARE assembly 
using two-photon fluorescence lifetime imaging (FLIM) of Förster resonance energy 
transfer (FRET) between three pairs of neuronal SNAREs in presynaptic boutons and 
pancreatic β cells in the islets of Langerhans. These FRET probes functionally rescue 
their endogenous counterparts, supporting ultrafast exocytosis. I show that 
trans-SNARE complexes accumulated in the active zone, and estimate the number of 
complexes associated with each docked vesicle. In contrast, SNAREs were 
unassembled in resting state, and assembled only shortly prior to insulin exocytosis, 
which proceeds slowly. I thus demonstrate that distinct states of fusion readiness are 
associated with SNARE complex formation. My FRET/FLIM approaches enable optical 
imaging of fusion readiness in both live and chemically fixed tissues.  
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Introduction 
  Ca2+-dependent exocytosis utilizes soluble N-ethylmaleimide- sensitive factor 
(NSF)-attachment protein receptors (SNAREs) for membrane fusion1. Three types of 
neuronal SNARE proteins—synaptosomal-associated protein 25 (SNAP25) and 
Syntaxin1A (Syx) in the plasma membrane (t-SNAREs) and vesicle-associated 
membrane protein 2 (VAMP2) in the vesicle membrane (v-SNARE)—assemble into 
α-helical four-helix bundles via their SNARE motifs through a zippering process that 
induces membrane fusion. It has been proposed that SNAREs partially assemble to form 
trans-SNARE complexes that connect the vesicle and plasma membranes and that  
Ca2+ triggers the completion of the zippering reaction, inducing exocytosis via  
Ca2+ sensors termed synaptotagmins and causing the formation of cis-SNARE 
complexes in the plasma membrane1,2. 
  This trans-SNARE mechanism is particularly suited to ultrafast exocytosis of 
synaptic vesicles in the active zone (AZ) of presynaptic terminals, where exocytosis is 
induced within a fraction of millisecond after increases in the cytosolic  
Ca2+ concentration3. No study, however, has ever succeeded in demonstrating the 
trans-SNARE complexes in AZ, because quantification of the assembly of the three 
proteins distinguishing their trans- and cis-states has been difficult in live cells4,5.  
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The trans-SNARE complex may not be formed before stimulation6 in the slow 
secretory cells5,7, whereas the trans- SNARE mechanism is still assumed in these cells8,9. 
It has thus been largely conjectural how the kinetic diversity of exocytosis depends on 
the states of SNARE assembly in living cells. 
  I therefore established Förster resonance energy transfer (FRET) measurements 
between three pairs of SNARE proteins using t-SNAREs as FRET donors. 
I utilized two-photon fluorescence lifetime imaging (FLIM) and the time-correlated 
single photon counting method to monitor FRET10,11. FLIM utilizes only the donor 
fluorescence, and can estimate inter-molecular FRET, differentiating the FRET 
efficiency and the binding fraction of two proteins, unlike ratiometric FRET 
measurement8,12,13. SNAREs are the most abundant proteins in presynaptic boutons14, 
and are suitable for carrying out FRET analyses with least perturbation of endogenous 
proteins. I here confirmed that my green fluorescent protein-fused FRET proteins for 
SNAREs could replace endogenous proteins for ultrafast exocytosis using SNAP25 
knockout mice. I established two independent (subtraction and gradient) methods to 
evaluate the fractions of trans-SNARE complexes in the presynaptic boutons  
of dissociated cultured cortical neurons. I applied the gradient method to hippocampal 
slice preparations, and found that trans-SNAREs were condensed in the AZ apposing 
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dendritic spines. Moreover, the number of trans-SNAREs associated with each docked 
vesicle in AZ was estimated using the volume of dendritic spine as a proxy for AZ size15. 
In a striking contrast, trans-SNAREs were absent in the resting state, and formed only 
after stimulation in the plasma membrane of β cells in the pancreatic islets of 
Langerhans, which undergo slow exocytosis of insulin ( ＞ 1s)12,16,17. Thus, I have 
established an approach to image fusion readiness in various secretory preparations. 
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Methods  
Ethical considerations.  
The use and care of animals in this study followed the guidelines of the Animal 
Experimental Committee of the Faculty of Medicine at the University of Tokyo. 
 
Construction of expression vectors.  
Complementary DNAs (cDNAs) of mouse SNAP25b, rat Syx and VAMP2 were kindly 
provided by Dr. T. Abe, and monomeric Turquoise (mtq) and Venus were provided by 
Dr. J. Goedhart and Dr. A. Miyawaki, respectively. Mammalian expression vectors for 
SNAREs were constructed using the ECFP－C1 or －N1 vectors (Clontech 
Laboratories, Inc., Mountain View, CA, USA), where ﬂuorescence protein was replaced 
with mtq or Venus, and the promoter was switched from chicken-Beta-Actin (CMV) to 
cytomegalovirus (CAG).  
 To construct the N terminal ﬂuorescent probes mtq－SNAP25 and Venus－SNAP25, 
SNAP25b was ampliﬁed with primers 
5’-GGCGAATTCAATGGCCGAGGACGCAG-3’and 
5’-CCTGTCGACTTAACCACTTCCCAGC-3’and inserted into the EcoRI/SalI site in 
the multi-cloning site of the C1 vector. To construct the double-ﬂuorescent probe  
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mtq－Venus－SNAP25, Venus was ampliﬁed with the primers  
5’ -GCCAGATCTATGGTGAGCAAGGGCGAG-3’ and  
5’-GGC GAATTCGCCTTGTACAGCTCGTCCATGC-3’ and inserted into the 
BglII/EcoRI sites of mtq－SNAP25 in the C1 vector. To construct the N terminal 
ﬂuorescent probes mtq－Syx or Venus－Syx, Syx was ampliﬁed with the primers 
5’-GCAAGCTT ATGAAGGACCGAACCCAGG-3’ and 
5’-CGGTCGACATTCCAAAGATGCCC CCG-3’ and inserted into the Hind III/Sal I 
site of the C1 vector. To construct the N terminal ﬂuorescent probes Venus－VAMP2 or 
mVenus－VAMP2, VAMP2 was ampli ﬁed with the primers 
5’-GCAAGCTTGTGGTGGTTCTGGTGGTACTGGTGGTTCTGGTAT 
GTCGGCTACCGCTGC-3’ and  
5’-CGCGGATCCCTAAGTGCTGAAGTAAACGATG-3’ and inserted into the 
HindIII/BamHI sites of the Venus- or monomeric Venus (mVenus)-containing C1 vector. 
Tetanus toxin (TeNT)－resistant VAMP2 (Q76V, F77W)61 was prepared with 
mutagenesis QuikChange II XL system, using primers  
5’-CCT CCAGGCAGGGGCCTCCGTGTGGGAAACAAGTGCAGCCAAGC-3’ and 
5’-GCTTGGCTGCACTTGTTTCCCACACGGAGGCCCCTGCCTGGAGG-3’.  
 To construct the C terminal ﬂuorescent probe Syx－Venus, Syx was ampliﬁed with 
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the primers 5’-GGCAAGCTTATCGCCACCATGAAGGACCGAACCCAGG-3’ and 
5’-CGCGTCGACATTCCAAAGATGCCC-3’ and inserted into the HindIII/ SalI sites of 
the N1 vector (italic sequence means Kozak (Koz) sequence). To construct the C  
terminal ﬂuorescent probes VAMP2－Venus, VAMP2 was ampli ﬁed with the primers 
5’-GCCGCTAGCCGCCACCATGTCGGCTACCGCTGCC-3’ and 
5’-CGCGTCGACAGTGCTGAAGTAAACGATGATGAT-3’, and Venus was ampliﬁed 
with the primers 5’-GGGGTCGACGGAGGATCAGGAGGATCAGGA 
GGAACAGGAAT GGTGAGCAAGGGCGAGG-3’ and 
5’-CGCGGATCCTTACTTGTACAGCTCGTCCATGC-3’ and the two digested PCR 
products were inserted into the NheI/BamHI sites of the N1 vector. CDNAs for the light 
chain of BoNTE, 51T52N53P, BoNTCα-51 (BoNTC) and TeNT were kindly provided 
by Dr. H. Gaisano, Dr. M. Jackson and Dr. T. Abe, respectively. I constructed pCAG－
Koz－BoNTE－LC－C1 by PCR ampliﬁcation of the toxin with the primers 
5’-GCCGGATCCCGCCACCATGCCAAAAATTAATAGTTTTAATTATAATGATCCT
GTTAATG-3’ and 
5’-GCCCCCGGGTTACCTTATGCCTTTTACAGAAACAATATTTTTACAAAATCTA 
ATG-3’ and its insertion into the NheI/SmaI sites of the C1 vector by blunting. pCAG－
Koz－BoNTC(51T,52N,53P)－LC－C1 was constructed by PCR ampliﬁcation of the 
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toxin with the primers 5’-GCCGCTAGCCGCCACCATGCCAATAACAATTAAC 
AACTTTAATTATTCAGATCCTG-3’ and 
5’-GCCGAATTCCTATTTATTATATAATGATCTACCATCTATTGCTTTATGACAAAA
TTTTGTAAATA AATAAAGC-3’ and its insertion into the NheI/EcoRI sites of the C1 
vector. pcDNA3-Koz-TeNT-LC was constructed by PCR ampliﬁcation of the toxin with 
the primers 5’-GGCGAATTCCGCCACCATGCCGATCACCATCAACAACT TCC-3’ 
and 5’-CTTGCGGCCGCTTAAGCGGTACGGTTGTACAGG-3’ and its insertion into 
the EcoRI/NotI sites of the C1 vector. All cDNA constructs were conﬁrmed by DNA 
sequencing. 
 
Dissociated cultured cortical neurons.  
Neocortical neurons were dissociated from male Sprague-Dawley rat brains (E19) or 
C57BL/6 mouse brains (E17.5) with 0.15 % trypsin in 1 % ethylenediaminetetraacetic 
acid (Invitrogen, Carlsbad, CA, USA) and DNase I (30 µg ml−1). The cells were plated 
on Laminin- and poly-D-lysine coated cover glasses at a density of 1.7×105 cells per 
cm2. The neurons were maintained in a serum-free medium (Neurobasal Medium; 
Invitrogen) supplemented with 500 µM glutamine (rat) or 1 % GlutaMax (mouse) and 
2 % B-27 Supplement (Invitrogen). Plasmids for the FRET probes and light-chain 
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clostridial toxins were transfected by lipofection with Lipofectamine 2000 (Invitrogen; 
0.25 %) according to the manufacturer’s protocol at 10–12 days after culture, and  
the cells were observed 1–2 days after lipofection with 0.8–1.2 µg DNA. The standard 
external bathing solution (SolA) contained 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 
mM CaCl2, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid-NaOH (pH 7.4) 
and 10 mM glucose for neurons or 2.8 mM glucose for islets (300–310 mOsm).  
The sucrose solution for stimulating presynaptic terminals contained 300 mM sucrose, 
and its osmolarity was 610 mOsml-1. SNAP25 KO mice were kindly provided from 
Wilson MC, Takahashi M, Yamamori S. Genotype was de ﬁned by PCR using cerebellar 
DNA and PrimeSTAR system (TaKaRa Bio). Primer mixtures were  
NEO588-Forward primer (5’-GCCGAATATCATGGTGGAAA-3’), 
25KO-57849FL (5’-CCCACATCTGCCTCCTTTCTGGTT-3’)  
and 25KO-58090RL (5’-GGGATGGGCACCATCAAATCTTTTC-3’, 20 µM each).  
240 bp band was detected with WT, while 530 bp band was detected with hetero or KO. 
Lentivirus carrying mtq－SNAP25 and Venus－VAMP2 (TeNT-resistant) was 
prepared62, and their promoter regions were substituted into CaMKII promoter. 
Lentivirus carrying mtq－SNAP25 (1–3×1011 genome copies per µl) was transfected  
in the ﬁrst day of culture to rescue survival, and lentivirus carrying Venus－VAMP2 
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(TeNT- resistant) was transfected 2 days before electrophysiological experiments.  
TeNT- (Lubio Science, 50 ng ml-1) was added 24–36 h before experiments. 
Tetrodotoxin (TTX) (Wako, Osaka, Japan,10 µM) was added 1–4 h before recordings. 
 
Electrophysiological experiments.  
The postsynaptic cells (DIV 12–16) were whole-cell clamped (holding potential = 
-70mV) and perfused with intracellular solution (in mM: CsCl 140, HEPES 10,  
MgATP 4, Na2GTP 0.3, Na2-phophocreatine 10, Alexa594 0.025, pH = 7.25 with 
CsOH). Theta-burst stimulation was applied (20 Hz×20 pulse, 100 µA amplitude,  
0.1 ms duration, 100–150 µm from dendrites) with 1 or 10 s interval. Extracellular 
solution was based on SolA containing 10 mM CaCl2, 100 µM cyclothiazide, 50 µM 
picrotoxin, 320 nM Na-pyruvate and pH 7.4. 
 
Experiments with hippocampal slices.  
For slice-cultured neurons, the expression vector was prepared by inserting 
double-ﬂoxed inverted-orientation (DIO) mtq2－Syx, Syx－mtq2, Venus－VAMP2 or 
VAMP2－Venus into the pAAV vector under the control of the human Syn (hSyn) 
promoter. The mtq232 cDNA was acquired from pCAG－mTq－C1 plasmid by 
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mutagenesis. Brieﬂy, an I146F mutation was introduced by PCR with primers 
(5’-AACTACTTTAGCGACAACGTCTAT ATC-3’, 
5’-GTCGCTAAAGTAGTTGTACTCCAGCTT-3’) using PrimeSTAR Max mutagenesis 
kit (Takara, Japan). The product was digested by Nhe I and BsrG I and was subcloned to 
the AAV vector. Recombinant AAV1 vectors were produced using previously described 
methods63. In brief, the expression vectors were transfected into AAV293 cells with 
pHelper (Stratagene, La Jolla, CA, USA) and pRep-Cap AAV1 (Applied Viromics LLC, 
Fremont, CA, USA) and the cell lysate was puriﬁed by CsCl gradient, dialysed and 
concentrated using Amicon Ultra ﬁlters (EMD Millipore, Billerica, MA, USA).  
Viral titre was determined by quantitative reverse transcription (qRT)–PCR using 
primers designed to detect the promoter regions. Hippocampal slices (350 µm thick) 
were prepared at P7 from SD rat, mounted on 0.4 µm culture plate inserts (EMD 
Millipore) and incubated at 35 ℃ in an atmosphere of 5 % CO2 in medium comprising 
50 % minimum essential medium (Invitrogen), 25 % Hanks’ balanced salt solution 
(Invitrogen), 25 % horse serum (Invitrogen) and 6.5 gl-1 glucose.  
AAV mixture (for example, AAV－hSyn－DIO－mTq2－Syx1A, AAV－hSyn－DIO
－Venus－VAMP2 and cre expression vector; AAV1. CAMKII 0.4 Cre.SV40 (Penn 
Vector Core, Philadelphia, PA USA)) was injected into CA3 pyramidal cell layer  
12 
 
at P8–9, using glass micropipette (diameter ~ 6 µm). The mixture also contained 0.03 % 
Fast Green. Transfection of pCAG－mCherry was done by Gene gun at P14–19 (3.5 µg 
per 30 µl gold) to visualize postsynaptic dendrite. In the electrophysiological 
experiments, slices were individually transferred to recording chambers and superfused 
with artiﬁcial cerebral spinal ﬂuid containing 125 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 
1 mM MgCl2, 1.25 mM NaH2PO4, 26 mM NaHCO3, 200 µM Trolox (Sigma-Aldrich 
Corporation, St Louis, MO, USA), 5 nM TTX and 20 mM glucose bubbled with 95 % 
O2 and 5 % CO2. All physiological experiments were performed at 32–34 ℃. 
For the imaging of cellular structures and Ca2+ transients evoked by electrical 
stimulation of presynaptic ﬁbres, neurons were transfected with mCherry and GCaMP6s 
(Plasmid #40753, Addgene, Cambridge, MA, USA), respectively, using a gene gun 
(PDS-1000; Bio-Rad Laboratories, Inc., Hercules, CA, USA) at P14 and used for 
experiments between P17 and P22. 
 
Culture and gene transfer with pancreatic islets.  
Pancreatic islets were isolated from male imprinting control region (ICR) mice ( ＞ 
8-weeks old) by collagenase digestion (Sigma-Aldrich Corporation) as described 
previously59. The islets were infected with a lentiviral vector carrying cDNA of the 
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ﬂuorescent probes for 24–72 h in Dulbecco’s modiﬁed Eagle’s medium (glucose 1 gl-1) 
supplemented with 10 % foetal bovine serum, 100 Uml-1 penicillin and 100 mg ml-1 
streptomycin36. Before imaging, the islets were transferred on to thin (0.1 mm) glass 
coverslips (Matsunami Glass Ind., Ltd., Osaka, Japan) in the recording chamber.  
As for the lentiviral vector system, in brief, cDNAs of ﬂuorescent SNAREs were 
inserted into the FCMV－WPRE vector, and virus particles were produced by their 
cotransfection with pCMV－VSV－G and pCMV－dR8.9 into lenti-X cells. The 
viruses were puriﬁed by ultracentrifugation and their titre was checked using an 
qRT–PCR titration kit (6×109 genome copies per ml; Lenti-X; Clontech Laboratories, 
Inc.).  
 
Immunostaining.  
For immunostaining, neurons in dissociated culture and pancreatic islets were washed 
with phosphate-buffered saline (PBS), ﬁxed with 4 % paraformaldehyde for 1 h (4 ℃), 
washed with PBS, permeabilized with 0.3 % Triton X-100 for 5 h and blocked with 
2.5 % horse serum and 0.15 % Triton X-100 for 8 h. The primary antibodies, 
anti-SNAP25 polyclonal antibody (SNAP25 speciﬁc and unable to bind SNAP23; 
immunogen: 195–206 AA; ab5666; Abcam, Cambridge, UK; 1:100), anti-VAMP2 
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rabbit polyclonal antibody (VAMP2-speciﬁc and unable to bind VAMP1, 3, 4 and 8; 
immunogen: 1–18 AA; ab3347; Abcam; 1:1000), anti-Syx antibody (also possibly binds 
Syx1B; ab41453; 1:200) and anti-synaptophysin antibody (MAB5258; EMD Millipore; 
1:200), were applied for 8 h, following which the samples were washed with PBS and 
the secondary antibody was applied (Alexa-Fluor 594-labelled goat anti-mouse 
Immunoglobulin G (H+L); Invitrogen; 1:800) for 8 h. After a ﬁnal wash,  
the preparations immersed in PBS were observed using two-photon microscopy. 
Fluorescence intensities of Alexa-Fluor 594 were quantiﬁed in many plasma membrane 
regions in the pancreatic islets or in the presynaptic terminal regions of neurons.  
The intrinsic expression of SNAREs was measured by Alexa-Fluor 594 intensity after 
secondary antibody labelling. The expression levels of mtq－or Venus－labelled 
SNAREs were compared with endogenous expression, taking into account the reduction 
in the ﬂuorescent intensity of mtq and Venus resulting from ﬁxation to 50.2 % and 31 %, 
respectively. 
 
Two-photon excitation FLIM.  
Two-photon excitation imaging was performed using an inverted laser-scanning 
microscope (FV1000 and IX81; Olympus Corporation, Tokyo, Japan) equipped with a 
15 
 
water-immersion objective lens (UPlanApo60xW/IR; numerical aperture 1.2; Olympus 
Corporation) and a femtosecond laser (Mai Tai; Spectra Physics Inc., Mountain View, 
CA, USA) for dissociated culture and β cells in the islets. For slice experiments,  
an upright microscope (BX61WI; Olympus Corporation) with a LUMPlanFL60xW 
objective (numerical aperture 0.9; Olympus Corporation) was used. Fluorescence of 
Alexa-Fluor 594, Venus and mtq was excited at 830 nm and detected at 570–650 nm, 
515–560 nm and 460–500 nm, respectively. The autoﬂuorescence was ＞ 2 %  
of mtq ﬂuorescence in my expression levels, and could not contribute to the lifetime 
measurement. To measure Venus intensity, the excitation wavelength was set at 970 nm. 
I conﬁrmed that a spectral bleed through of Venus into the mtq channel was 
undetectable in my expression levels irrespective of the excitation wavelength of 830 or 
970 nm even after repeated imaging sessions. Laser power was set at 4.5 mW.  
Pixel size was 0.10 µm and 512×512 pixels, with a frame rate of 1 frame per 6 s.  
For the acceptor bleaching experiment, dissociated culture preparations were irradiated 
with a Hg lamp at wavelength of 500–550 nm for about 40 min. FLIM of dissociated 
culture and β cells in the islets was performed using a GaAsP avalanche-diode hybrid 
detector (R10467U-40; Hamamatsu Photonics K. K., Hamamatsu, Japan) and analysed 
using SPCImage software (SPC-150; Becker & Hickl GmbH, Berlin, Germany).  
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For hippocampal slice preparations, I used GaAsP PMT (H7422; Hamamatsu Photonics 
K. K.) and analysed data using PicoHarp (PicoQuanta GmbH, Berlin) and homemade 
MATLAB software (MathWorks, Inc., Natick, MA, USA). The ﬂuorescence decay time 
course ﬁtted a double-exponential function, with time constants of 0.5 and 3.5 ns  
for mtq, which were convoluted with a Gaussian system response function with a s.d.  
of 0.1 ns. A faster decay component (A1) values were not critically dependent on the 
fast time constant between 0.5 and 1 ns. The fast time constant was well-predicted by 
the short linkers between SNAREs and mtq (or Venus) of 18–25 amino acids in my 
constructs with predicted lengths of 2.3–2.7 nm, assuming that the length of ﬂexible 
linker was estimated as 0.86 nm per 2.4 amino acids64, and that the physical length 
depends on the square root of the number of amino acids65,66. Comparable lengths of 
linkers were used for FRET/FLIM probes, and resulted in similar fast lifetime decays  
in other studies26,67. Because the ﬂuorescence decay of mtq was 3.5 ns (τ2) and it did not 
decay completely within the 12.5 ns sampling interval (T), Ai obtained from 
doubleexponential ﬁtting was multiplied by (1-e-T/τi), and then normalized by A1+A2 = 1 
(incomplete multi-exponential ﬁtting)68. This process is simple, and the usage of 
ﬂuorescent probe with a slow ﬂuorescent lifetime decay is beneﬁcial for a better 
separation of the fast FRET component. The A1 fractions were pseudocolour coded, and 
17 
 
the luminosities of the colour code were modulated on the basis of the brightness of mtq. 
In the time-lapse experiments, each image of A1 was calculated with a detection time of 
20 s and ﬁltered by a median ﬁlter with a size of 2×2 pixels. In the time-lapse 
experiments, the A1 fractions were obtained in two different ways. One way was  
the curve ﬁtting of the average of data from many boutons. The other way was to use 
the average lifetime to calculate A1, assuming that τ1 and τ2 were constantly 0.5 and 3.5 
ns and using the equations (𝑇𝑎𝑣𝑒 − 𝑇0) = 𝐴1 𝜏12 + 𝐴2 𝜏22𝐴1 𝜏1 + 𝐴2 𝜏2  and A1 + A2 = 1, where Tave is 
the average lifetime and T0 is the offset arrival time, obtained by ﬁtting the ﬂuorescence 
of a large region-of-interest10. To measure mtq and mCherry in hippocampal slice 
preparations, the excitation wavelength was set at 900 nm and ﬂuorescence was 
detected at 460–500 nm and 570–650 nm, respectively. Laser power was set at 5–8 mW. 
Pixel size was 0.079 µm (128×128 pixels). Three-dimensional FLIM images were 
obtained by 20 s imaging for each depth with 1 µm interval (seven depths).  
The Venus images were acquired at 520–560 nm at 980 nm excitation wavelength, and 
Z-stacks had an interval of 1 µm with a frame rate of 1 frame per 0.8 s.  
I estimated spine-head volume (V) from the total ﬂuorescence intensity (F) in the 
stacked images of spines. A conversion coefﬁcient, V/F, was obtained from the 
ﬂuorescence proﬁle of the largest, roundest spine on each dendrite69,70, which was 
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subsequently applied to all other spines on the dendrite. For Ca2+ imaging, two-photon 
excitation was performed at 970 nm and the ﬂuorescence intensity of GCaMP6s was 
measured at 490–540 nm. The signals were obtained from all spines. Pixel size was  
0.1 µm, and images were acquired at a rate of 1 frame per 0.22 s. Two-photon images 
were analysed using IPLab (Scanalytics Inc., Milwaukee, WI, USA), ImageJ (the 
National Institutes of Health, Bethesda, MD, USA; http://rsb.info.nih.gov/ij/) and 
MATLAB software. Detection of insulin exocytic events was performed as described  
in a previous paper12. Shortly, I immersed the pancreatic islets expressing the FRET 
probes with SolA containing 0.3 mM Alexa594 hydrazide (Invitrogen), and stimulated 
insulin secretion with 16 mM glucose and 5 nM GLP-1. The individual exocytic events 
were captured with 2P imaging by the sudden appearance of small ﬂuorescent spots 
inside the islet16. I simultaneously performed time-lapsed measurements of Alexa 594 
intensity at 570–650 nm (Fluoview) and FLIM of mtq at 460–500 nm with an interval 
of 1.8 s. I used excitation wavelength of 830 nm, and the power of 4–5 mW.  
Exocytic events detected within 40 min were analysed. 
 
Statistical analysis.  
The FRET images which did not have sufﬁcient photon counts were discarded from 
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statistical analysis. Comparable numbers of images were used as in previous 
studies8,12,13. Histogram bars represent the mean ± s.e.m. The signiﬁcance of each A1 
fraction versus 0 % was tested using the Wilcoxon signed-rank test. The differences 
between two groups were tested using the Mann–Whitney U-test.  
For multiple comparisons between groups, the signiﬁcance was ﬁrst examined using the 
Kruskal–Wallis test, followed by Scheffé’s or Steel’s tests. The signiﬁcances of the 
correlation coefﬁcient were tested using Spearman’s rank correlation coefﬁcient. No 
randomization and blinding was used to analyse the data. 
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Results 
Estimation of binding fractions of SNAREs with FRET/FLIM.  
To quantify assembly between the three pairs of SNARE proteins, I labelled the 
t-SNAREs SNAP25b and Syx with mtq to form FRET donors and VAMP2 and Syx 
with the FRET acceptor Venus (Fig. 1a―f and Fig. 2). The constructs were lipofected 
into cortical neurons in dissociated culture. Images were acquired for 60 s to accumulate 
a sufﬁcient number of photons for constructing ﬂuorescence lifetime curves.  
The ﬂuorescence lifetime of mtq－SNAP25b (Fig. 1g―i) was monoexponential, 
with a time constant of ~3.5 ns, in synaptic boutons (Fig. 1 h,i; A2), indicating that mtq 
is an appropriate probe for quantitative FLIM18,19. The A1, with time constants of 0.7 ns 
(τ1), was evident when both mtq and Venus were fused with SNAP25b in tandem  
(Fig. 1j―l; A120). The A1was obtained by double-exponential ﬁtting of photon count 
decays by ﬁxing the slow component as 3.5 ns (τ2; Methods). The A1 fraction was 
estimated to be 63.5 % (Fig. 1m) instead of 100 % that would be expected for a tandem 
probe. This is in line with a previous study10, and is explained by incomplete maturation 
or a dark state of Venus. This factor was left uncorrected to avoid possible 
overestimation of molecular interactions10.  
 The values of τ1 for all the probes (Figs. 1―23) were estimated in between 0.5 and 
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1.5 ns, indicating that FRET efﬁciency ( = 1-τ1/τ2) was between 0.85 and 0.57 and that 
distances between the two ﬂuorescent proteins in the binding state were within the 
Förster radius, and therefore the A1 value was used as an estimate of the binding 
fraction (%) of a SNARE pair. I ﬁrst analysed FRET probes in neurons in dissociated 
culture and then applied them to intact synapses in slice preparations, as I am using 
two-photon imaging, then compared the results with those of β cells in the islets of 
Langerhans. 
 
Syx-based FRET probes in synaptic boutons.  
The time constant of the ﬂuorescence decay of mtq－Syx was monoexponential and 
unaffected by chemical ﬁxation (Fig. 3a―d). I conﬁrmed that Syx-positive boutons 
were presynaptic structures by counterstaining mtq－Syx preparations with 
anti-synaptophysin antibody (Fig. 3c). There was no gradient of A1 values within  
a single bouton around the synaptophysin-positive spots (Fig. 3c; A1). However, 
signiﬁcant A1 fractions appeared within a bouton (Fig. 4a,b) when Venus－VAMP2 was 
cotransfected with mtq－Syx. I conﬁrmed that the A1 fraction represented FRET, 
because it was eliminated by bleaching of Venus (Fig. 4c,d). Comparable A1 fractions 
were obtained when I used the monomerizing A206K mutant of mVenus (Fig. 4e,f),  
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in which dimerization of  Venus and binding between mtq and Venus were 
minimized21.The A1 values did not seem to depend on expression levels of the donor 
mtq－Syx, but correlated with the expression of the acceptor Venus－VAMP2 (Fig. 
5a,b). Endogenous expression of Syx and VAMP2 were estimated using an antibody 
against Syx and VAMP2 as 80 A.U. and 540 A.U., respectively (Fig. 5c,d; Methods), 
where the speciﬁcity of the antibodies to VAMP2 was conﬁrmed by transfecting the 
light chains of TeNT, which selectively cleaves VAMP2, and removed 90 % of 
antigenicity (Fig. 6a,b). The A1 fraction was 34.1 % in boutons when expression levels 
of VAMP2 were similar to endogenous levels (Fig. 5b). This A1 fraction should predict 
the binding fraction of endogenous Syx with VAMP2, given that the FRET signal 
showed an approximately linear increase with VAMP2 expression levels (Fig. 5b).  
The A1 fraction was not ascribed to molecular crowding of SNAREs in AZ because the 
homotypic binding between mtq－Syx and Venus－Syx (Fig. 7a―f), and between mtq
－SNAP25 and Venus－SNAP25 (Fig. 7g―m), were negligible at all expression levels, 
whereas all three heteromeric pairs of SNAREs (Syx/VAMP2, SNAP25/VAMP2 and 
SNAP25/Syx) showed signiﬁcant binding (Fig. 8a―c; see Fig. 13e and Fig. 14e).  
   Chemical ﬁxation did not affect ﬂuorescence lifetimes22 and FRET values  
(Fig. 8a―c), and I found that synaptophysin-positive sites in boutons showed FRET in 
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the A1 fraction of 38.8 %, whereas the synaptophysin-negative parts showed FRET in 
the A1 fraction of 17.4 % (Fig. 8d; see Fig. 18j―l for more precise arrangement of 
vesicles and the high FRET region). This suggests that the Syx- and VAMP2-binding 
fractions were larger in the AZ. In contrast, the A1 fraction was only ~ 22 % in axons on 
average (Fig. 8d). These binding fractions included both trans- and cis-SNARE 
complexes.  
   To quantify cis-SNARE complex separately from trans-complex1, I labelled 
SNAREs at their C-termini so that FRET occurred only for cis-SNARE complexes (Fig. 
9a). A1 values were estimated to be 24.7 % at the endogenous level of VAMP2 
expression (Fig. 9b―g). Since the total fraction of SNARE complexes was estimated as 
34.1 % (Fig. 8c), this provided an estimate of the fraction of Syx that forms 
trans-SNARE complexes with VAMP2 of 9.4 % ( = 34.1-24.7) on average (Table 1; 
subtraction method). Unlike the A1 fractions of total SNARE complexes (Fig. 8c),  
those of cis-SNAREs were similar between boutons and axons (Fig. 9g; 24.7 versus 
21.5 %). Moreover, the A1 fractions in the boutons (A1bouton) were similar to those  
in the axons (A1axon) surrounding each bouton (Fig. 9h), suggesting that cis-SNAREs 
are diffusible and equilibrate along axons. Furthermore, cis-complex was nearly 
eliminated by lipofection of the light chain of botulinum toxin, BoNTE,  
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which selectively cleaves SNAP25 and blocks exocytosis (Fig. 9g and Fig. 10a,b)23,24, 
suggesting that cis-SNARE complexes form at boutons by exocytosis and diffuse into 
axons.  
   To test whether trans-SNARE complexes are converted into cis-SNARE complexes 
by exocytosis, I stimulated the boutons with a hypertonic sucrose solution, which is 
known to induce the exocytosis of vesicles in the readily releasable pool25. I found that 
cis-SNARE complexes formed in the boutons as the decay lifetime shortened there  
(Fig. 10c), suggesting that cis-SNARE complexes form from trans-SNARE complexes 
by exocytosis1. For time-resolved analysis, I accumulated images for 18 s from several 
boutons to which sucrose was applied. I therefore estimated the A1 fraction from both 
ﬁtting of decay time courses and the average lifetime (TA1bouton; open circles), assuming 
a τ1 of 0.5 ns (Methods)26. Increases in the A1 fraction were consistently estimated by 
the two methods (mean ± s.e. of seven experiments: 11.8 ± 1.7 and 12.9 ± 3.7 % 
; Fig. 10d). This value was similar with the fraction of trans-SNARE complexes of 
10 % estimated by the subtraction method (and the gradient method, see below), 
suggesting that all trans-SNARE complexes were converted into cis-SNARE complexes 
after exocytosis. Consistent with this observation, the sucrose-induced increases in A1 
values were abrogated by BoNTE treatment (Fig. 10e). These data support that 
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trans-SNAREs in the boutons identiﬁed by FRET of mtq－Syx/Venus－VAMP2 
actually represented the ternary complexes, and prepared for exocytosis. The A1 
fractions also increased in axons after sucrose stimulation (Fig. 10c,d, TA1axon), 
conﬁrming the diffusion of cis-SNAREs into axons13.  
  Transfection of neurons with BoNTE reduced (but did not eliminate) the A1 fraction 
of the mtq－Syx/Venus－VAMP2 probe from 34.1 to 16.3 % in boutons (Fig. 11 a―c). 
The remaining complexes may be trans-SNAREs, because BoNTE nearly eliminated 
cis-SNARE (Fig. 9g), possibly by blockade of exocytosis (Fig. 10a). In fact, the 
BoNTE-resistant fraction (16.3 %) was close to the trans-complex fraction estimated 
with the subtraction method. It is surprising that the trans-complex can be formed to  
a similar degree even without SNAP25 (Fig. 11c), suggesting that AZ helps assemble 
the binary complex.  
  The SNARE complexes in axons are unlikely to be trans-complexes because 
vesicles are not docked in the axon. In fact, the amount of total SNARE complexes 
present in axons (Fig. 11b,c; 22.4 %) was similar to that of cis-SNARE complexes  
(Fig. 9g; 21.5 %) in axons. Because the fractions of cis-SNARE were similar between 
axons and boutons (Fig. 9g,h; 24.7 %), the fraction of trans-SNARE complexes in 
boutons can be calculated by the difference between the SNARE complexes in boutons 
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and axons as 11.7 % ( = 34.1-22.4; Table 1; gradient method) similar with the value 
(9.4 %) obtained by the subtraction method. The gradient method could be applied to 
each bouton because the fraction of SNARE complexes in each bouton (A1bouton) was 
linearly related to that of the axon surrounding the bouton (Fig. 11d, A1axon) and 
subtraction of A1axon from A1bouton yielded the fraction of trans-SNARE in each 
bouton as 11.6 ± 1.0 % (n = 36; Fig. 11e), independently of the A1axon values. The 
sizes of boutons showed only a weak correlation with the trans-SNARE fractions  
(Fig. 11f), indicating that the sizes of boutons are not a good indicator of presynaptic 
function27, unless the sizes of AZs were taken into account (see Fig. 18n). I also found 
that TTX reduced SNARE complexes along axons within 1h (Fig. 12a), indicating that 
cis-SNAREs in the axons were dependent on neuronal activity, consistent with the 
results with BoNTE (Fig. 9g). Importantly, however, the amount of trans-SNARE 
complexes in the boutons estimated by the gradient method was unaltered up to 4 h  
(Fig. 12b). This indicated that the abundant trans-SNAREs in the boutons were 
assembled in the absence of action potentials, and supported the trans-SNARE model 
for ultrafast exocytosis5.  
 
SNAP25-based FRET probes in synaptic boutons.  
I examined whether the fraction of trans-SNARE complexes obtained by 
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SNAP25-based FRET probes was similar (Fig. 13a,b). The A1 fraction was 36.7 %  
in the boutons when expression levels of VAMP2 were similar for the endogenous level 
on average (Fig. 5d and Fig. 13c―e). The difference between the SNARE complexes in 
boutons and the surrounding axons estimated trans-SNARE to be 14.0 % ( = 36.7-22.7) 
in a bouton (Table 1). This value was similar to those obtained using Syx-based probes 
(11.7 %, Table 1), suggesting that the expression levels of SNAP25 and Syx were 
similar in boutons. Indeed, the endogenous expression of SNAP25 and Syx was 
estimated to be 98 A.U. and 80 A.U., respectively, using mtq probes in boutons (Fig. 5c 
and Fig. 9f ), as in the whole brain preparation14. The speciﬁcity of the antibodies to Syx 
and SNAP25 was conﬁrmed by transfecting the light chains of BoNTC1α-51 which 
selectively cleaves Syx28 and BoNTE (Fig. 6b and Fig. 13f,g). The fraction of 
trans-SNAREs was also estimated using mtq－SNAP25b and Venus－Syx  
(Fig. 14a―e). The A1 fraction was 29.5 % in boutons and 16.2 % in axons for the 
endogenous expression level of Syx (Fig. 7f and Fig. 14e), predicting that 13.3 %  
( = 29.5-16.2) exists as trans-SNARE complexes (Table 1).  
 The A1 fractions in the boutons were reduced to 14.5 % and 12.0 % by BoNTC1α-51 
(Fig. 13e) and TeNT (Fig. 14e―g)24, respectively. It was again noted that 
SNAP25/VAMP2 and SNAP25/Syx binary complexes remained in boutons, even 
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though those in axons were eliminated (Fig. 14e―g). The fractions were similar with 
the estimated SNARE complex fractions of 14.0 % and 13.3 % (Table 1), respectively, 
as in the case with BoNTE (Fig.11c and Fig. 13e), suggesting the existence of efﬁcient 
mechanisms to assemble the binary complexes in AZ. 
 To conﬁrm that the FRET probes did not affect the dynamics of exocytosis and 
reﬁlling of vesicles, I examined excitatory postsynaptic currents (EPSCs) evoked by 
electrical stimulation in the presence of cyclothiazide, which prevents the 
desensitization of AMPA receptors (Fig. 15a)29, and studied the time courses of ultrafast 
exocytosis, depletion and reﬁlling of glutamatergic vesicles in wild-type (WT) mice by 
repetitive stimulation at 20 Hz 20 times (Fig. 15b―g). SNAP25 was replaced with  
mtq－SNAP25 using knockout mice30 where synaptic transmission was abolished (Fig. 
15h,i), and rescued by mtq－SNAP25 (Fig. 15j,k). VAMP2 was then cleaved by TeNT 
treatment, and rescued by TeNT-resistant VAMP2 (VAMP (TeNTR)) fused with Venus 
(Fig. 15l―q). In this preparation, I found the same ultrafast exocytosis as in the WT 
(Fig. 15a,n). EPSCs occurred with delays of about 2.5 ms, and the time to peak was 
0.4ms in the WT, SNAP25 KO with mtq－SNAP25 and SNAP25 KO with 
mtq-SNAP25/Venus－VAMP (TeNTR) in the presence of TeNT. Thus, the kinetics of 
exocytosis was unaffected. Furthermore, ultrafast exocytosis was depleted within    
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20 times of stimulation (Fig. 15o). This depletion lasted for at least 1s (Fig. 15o,q), and 
recovered over a 10-s interval as in the WT (Fig. 15e). 
Thus, the depletion and reﬁlling of vesicles were unaffected by replacing endogenous 
proteins with mtq－SNAP25/Venus－VAMP2. The FRET levels were similarly 
estimated as 24.4 % in boutons and 13.1 % in axons (Fig. 16a,b and Table 1), predicting 
trans-SNAREs to be about 11.3 % of the SNARE population, where the average 
expression levels of mtq－SNAP25 and Venus－VAMP2 were similar to endogenous 
levels (Fig. 5d and Fig. 9f). I therefore conclude that my SNARE FRET/FLIM probes 
can measure the functional states of SNAREs without affecting the dynamics of 
SNAREs. 
 
Imaging of presynaptic SNARE complexes in slice cultures.  
I next applied my two-photon FRET/FLIM probes to the CA1 region of hippocampal 
slice cultures, where postsynaptic spines can be identiﬁed and the sizes of AZ can be 
estimated from the size of spines15,26,31. Fluorescence decay of mtq2－Syx32 was 
monoexponential with a time constant of 3.8ns in the Schaffer collaterals in the CA1 
region (Fig. 17). I ﬁrst conﬁrmed whether the trans-complex fraction was similar in the 
slice preparation by sucrose. To express the Syx－mtq2/VAMP2－Venus probes in 
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Schaffer collateral ﬁbres in the CA1 region, AAV1 vectors were injected into the CA3 
region (Fig. 18a,b). FRET of cis-complexes between Syx－mtq2 and VAMP2－Venus 
was 3.7 ± 1.2 % (n = 24) in the resting state, and the A1 fraction was increased to 
13.6 % ± 1.8 % (n = 24) during sucrose stimulation (Fig. 18c,d). The fractions of 
cis-SNARE in the resting state were similar between boutons and axons (Fig. 18e) as 
seen in dissociated cultures (Fig. 9h), supporting the idea that cis-SNAREs diffuse into 
axons in slice preparations (Fig. 18c), as in dissociated culture.  
 To measure the distribution of trans-SNARE complexes, I expressed  
mtq2－Syx/Venus－VAMP2 probes in Schaffer collateral ﬁbres using an AAV1  
(Fig. 18f), and a gene gun was used to express a plasmid containing mCherry in CA1 
pyramidal neurons to visualize dendritic spines. I identiﬁed possible contacts between 
mtq2－positive boutons and mCherry－positive spines by three-dimensional inspection 
(Fig. 18g,h), where a single laser beam (900 nm) was used so that the position of two 
images was completely identical. I found that, in cases where presynaptic boutons 
overlapped with spines (Fig. 18i), mtq2－Syx showed high FRET values in the 
overlapping region, potentially representing AZ (Fig. 18j). Such overlaps should reﬂect 
the interdigited nature of spine synapses33. In fact, I also found VAMP2 clusters in such 
presynaptic boutons (Fig. 18k). When I analysed the ﬂuorescent proﬁles along the spine 
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(Fig. 18l), the high FRET regions were closer to the spines than to the presynaptic 
proﬁles labelled with VAMP2 or Syx, consistent with the localization of the AZ at the 
edge of presynaptic vesicle cluster34. In my expression level, mCherry ﬂuorescence was 
not detectable in the mtq channel, and could not be a reason for the high FRET region at 
the border of boutons.  
 The fractions of trans-SNARE both in boutons on average and within AZ were 
estimated in the presynaptic boutons, which displayed a clear overlap with a dendritic 
spine (Fig. 18i). The trans-SNARE values were estimated by subtracting the A1 values 
in the axons surrounding the bouton (A1axon) from those of all boutons (Fig. 18m; 
A1bouton-A1axon), indicating that the average FRET values in the boutons showed a 
correlation with spine volume with the mean trans-SNARE fraction of 11.9 % (Table 1), 
reﬂecting that AZ sizes showed strong correlation with spine volumes15. To estimate the 
trans-SNARE fraction within AZ, I used the area of boutons overlapping with spines, 
and obtained the peak values (A1s) in the images which were smoothed to render the 
FWHM spatial resolution to 0.5 µm. The peak values of trans-SNARE fractions for AZ 
were correlated with volumes in small spines (Fig. 18n), possibly because of the limited 
spatial resolution, and because the fraction of trans-SNAREs was constant irrespective 
of AZ size. In fact, the peak values were independent of spine volumes for those spines 
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＞ 0.2 µm3 (Fig. 18n), where corresponding AZ had an area ＞ 0.2 µm2 and a diameter 
＞ 0.5 µm so that the peak value was not attenuated by the limited spatial resolution15. 
For Fig. 18n, I intentionally selected large spines, as they were relatively infrequent.  
I estimated the fraction of trans-SNAREs in AZ using the spines ＞ 0.25 µm2 as 
27.7 % ( = A1s-A1axon; Table 1).  
 To examine the presynaptic functions of spine synapses, I expressed a Ca2+ indicator 
probe, GCaMP6s, in CA1 pyramidal neurons using a gene gun for monitoring Ca2+ 
responses in individual spines (Fig. 19a―d) whose presynaptic ﬁbres were stimulated 
by a glass electrode. The release probabilities of the boutons were estimated by 
repetitive stimulation (20 – 50 times) of presynaptic ﬁbres at 0.1 Hz, and spine Ca2+ 
increases ＞ 3 s.d. of the noise level (100 % changes in GCaMP6s) within 0.3 s of 
stimulation were considered as successful transmission. I found that the spine size 
strongly correlated with the release probabilities of presynaptic terminals (Fig. 19e), 
possibly owing to their correlations with the sizes of AZ35 and the amount of 
trans-SNARE (Fig. 18n). 
 
SNARE complexes in β cells in the islets of Langerhans.  
Finally, I examined SNARE complexes in β cells in the islets of Langerhans (Fig. 20a), 
which I transfected with SNARE probes by lentivirus (Fig. 20b)36. I chose cells with 
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discrete membrane staining inside the islets (Fig. 20a, arrow); 80 % were β cells 
undergoing insulin secretion12,16. When the islets were transfected with mtq－SNAP25b 
and Venus－Syx (Fig. 20b), a signiﬁcant A1 fraction appeared in the plasma membrane 
(Fig. 20c―f). The A1 value was estimated to be 5.3 % at the endogenous expression 
level of Venus－Syx (Fig. 21a―d). The existence of SNARE complexes in the islets is 
consistent with a previous study in which the assembly of SNAP25 with Syx was 
ratiometrically estimated using intramolecular FRET of SNAP2512. Using anti-SNARE 
antibodies and mtq－SNARE probes, I estimated the endogenous levels of SNAP25 and 
Syx expression to be 92 A.U. and 10 A.U., respectively (Fig. 21c,e). Expression of 
SNAP25 was nine times greater than that of Syx, as in PC12 cells37 and may correlate 
with the small fraction of SNAP25-forming complexes with Syx.  
 In contrast, binding between t-SNAREs and VAMP2 was not signi ﬁcant (Fig. 20g―l): 
decay time courses were almost mono-exponential (Fig. 20i,l) when islets were 
transfected with mtq－Syx or mtq－SNAP25b and Venus－VAMP2 (Fig. 20b).  
The A1 fractions were ＜ 2 % and were not signiﬁcantly different from zero for the 
endogenous expression levels of VAMP2 (Fig. 20f,Fig. 21f and Fig. 22). Thus, no 
signiﬁcant trans-SNARE complexes exist in the plasma membranes of β cells (Table 1). 
 To examine whether SNAREs probes reﬂected functional states in β cells, 
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 I simultaneously imaged individual instances of exocytosis of insulin vesicles with an 
extracellular tracer, Alexa594 (Fig. 23a,b), and FRET values of  
mtq－SNAP25b/Venus－VAMP2 for the region with a diameter of 0.5 µm where 
exocytosis was imaged during islet stimulation by a high-glucose solution (16 mM,  
Fig. 23c―e). I accumulated ﬂuorescence for 1.8 s, and estimated the A1 fraction from 
the average lifetime, assuming τ1 of 0.5 ns as in Fig. 10d. SNAP25b was used instead of 
Syx, because endogenous expression levels of Syx in β cells were low,  
and its overexpression was often toxic. I frequently found increases in FRET values 
before individual exocytotic events (1.8–10.8 s, mean = 5.9 ± 0.3 s, n = 61).  
The peak value was 8.3 ± 1.6 % in averaged traces from 61 events (Fig. 23f). Such 
FRET signals were only found in the region surrounding exocytotic events (Fig. 23g). 
These data suggest that SNAREs are unassembled in the resting state, and they 
assemble only shortly before exocytosis in β cells (Fig. 23h), unlike synaptic vesicles  
in boutons where trans-SNAREs are already assembled in the resting state for ultrafast 
exocytosis (Fig. 23i). 
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Discussion  
I have thus succeeded in estimation of trans-SNARE fractions of t-SNAREs in neurons 
and β cells using FRET probes of SNARE proteins. I conﬁrmed that the green 
ﬂuorescent protein-fused probes could replace the functions of endogenous proteins for 
ultrafast exocytosis. The trans-SNARE fraction was consistently estimated as about 
10 % in the entire bouton with various probes, and about 25 % in AZ, while absent from 
axons and β cells (Table 1). It is of note that the gradient method with VAMP2 can 
estimate the fraction of trans-SNARE in individual boutons. This is based on the ﬁnding 
that most SNARE complexes in the axon were cis-SNAREs, and that the fractions of 
cis-SNARE were similar between boutons and their surrounding axons (Fig. 9h and Fig. 
18e), possibly because both cis-SNARE and free Syx can diffuse along axons, and their 
proportion is determined by a balance between exocytosis and the actions of NSF38,39.  
I found that the release probability is proportional to sizes of spines, and therefore to AZ 
sizes and to the fraction of trans-SNAREs. My two-photon FRET approaches may be 
useful for long-term functional imaging of presynaptic terminals whose functional states 
cannot simply be inferred from their sizes (Fig. 11f)27, unlike postsynaptic dendritic 
spines40. The fraction of VAMP2-forming complexes with Syx was estimated to be 
2–5 % by a previous study of presynaptic boutons13 in which VAMP2 was used as a 
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FRET donor. This fraction was small because the FRET signal was diluted by VAMP2 
in non-docked vesicles, the major component (90 %) of vesicles in a bouton.  
In contrast, I used t-SNARE as FRET donor, and the FRET values are unaffected by 
non-docked vesicles and report the readiness of exocytosis of the plasma membrane.  
I found that ~ 27.7 % of Syx formed trans-SNARE complexes in AZ (Fig. 18n). 
Recently, the amount of Syx1A was estimated14 as 20,096 molecules per bouton with an 
average surface area of 2.31 µm2. If I assume this value, the number of Syx in AZ per 
0.1 µm2 should be estimated as 870 ( = 20,096×0.1/2.31), because Syx homogenously 
distribute in bouton (Fig. 3a and Fig. 18g)14. It has been reported that the number of 
docked vesicles correlates with the area of the AZ, and 25 vesicles are docked per  
0.1 µm2 of AZ41,42. By deﬁnition, the size of the AZ is nearly the same as the PSD, and 
the size of the PSD is proportional to the volume of the spine15, such that a spine with 
0.1 µm2 PSD has 0.1 µm3 spine volume15,27,41. Thus, the number of trans-SNAREs 
associated with each docked vesicle is estimated as 9.6 ( = 870×0.277/25).  
Note all these trans-SNAREs may not be used for ultrafast exocytosis. In fact, previous 
studies suggested the number of functional trans-SNAREs required for ultrafast fusion 
reaction to be in between two and nine43–46.  
 The larger trans-SNARE fraction in AZ (27 %) than the mean value (10 %) in 
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bouton reﬂects the accumulation of docked vesicles in AZ. I demonstrated that AZ 
promoted assembly of binary SNARE complexes (Syx/SNAP25, Syx/VAMP2, 
SNAP25/VAMP2) even though one type of the SNARE proteins was cleaved by 
clostridial toxins, possibly reﬂecting the fact that docking of synaptic vesicles is often 
unimpaired by toxin treatment5. An AZ protein, Munc13, may contribute in such 
trans-SNARE formation, because it induces Syx open form47, and its MUN domain can 
bind free SNARE proteins48,49. Alternatively, they may be due to tethering mechanisms, 
such as those involving voltage-gated calcium channels50.  
 I found that the trans-SNAREs were accumulated but not exclusively localized in 
AZ. This is consistent with the observation that docked vesicles are found outside the 
AZ42,51, and ectopic exocytosis of synaptic vesicles outside AZ was reported52–54. It may 
also relate to the fact that releasable vesicles are formed close to the Ca2+ channels after 
positional priming55, and that the most AZ proteins show some condensation in the AZ, 
but distributed throughout a bouton14. Such ectopic trans-SNAREs may be utilized for 
asynchronous exocytosis56 and tonic exocytosis57 where increases in [Ca2+]i spread 
outside of AZ. 
 My data indicate that a major fraction of SNARE proteins is unassembled (unitary) 
outside AZ even in neurons (Table 1)5, and such unitary SNAREs are predominant in β 
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cells, where trans-SNARE complexes are nearly absent, in line with the fact that insulin 
vesicles are mostly non-docked to the plasma membrane before exocytosis5,58.    
Indeed, I conﬁrmed the formation of trans-SNARE complex shortly preceding slow 
insulin exocytosis (Fig. 23f)16,17,59. Unitary SNAREs may also be utilized in neurons, 
for example, in slow exocytosis of large dense-core vesicles60.  
In summary, I directly demonstrated an extreme diversity in the initial states of 
SNARE proteins in synapses and secretory cells, consistent with the marked differences 
in their readiness for exocytosis. I have thus established the technique to image the 
readiness for exocytosis in the plasma membrane without actually triggering exocytosis. 
My two-photon FRET/FLIM methods are widely applicable for functional imaging of 
presynaptic terminals and secretory cells in both live and ﬁxed preparations 71. 
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Figures and Figure legends 
 
 
Figure 1 | Combinations of FRET/2pFLIM probes for SNAREs.  
(a―f) Schematic drawing of combinations of probes whose constructs are depicted in 
Fig. 2. mTurquoise was used as a donor and Venus as an acceptor. The N terminal end 
of synaptosomal-associated protein 25 (SNAP25b) was labelled with either mTurquoise 
(mtq, a) or in tandem with mtq and Venus (b) to measure the folding fraction of Venus. 
The binding fractions (or A1 fractions) of syntaxin1A (Syx) with vesicle-associated 
membrane protein 2 (VAMP2) in the cytosol were detected by mtq－Syx and  
Venus－VAMP2 (c). The cis-complex of Syx with VAMP2 was detected by Syx－mtq 
and VAMP2－Venus (d), because FRET occurs only when they are present in the same 
membrane. The assembly of SNAP25 with VAMP2 or Syx was detected by  
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mtq－SNAP25 and Venus－VAMP2 (e) or Venus－Syx (f). (g) Images of synaptic 
boutons in rat cortical dissociated culture lipofected with mtq－SNAP25 (scale bar, 5 
µm). The left image shows the fluorescence intensity of mtq－SNAP25, 
while the right image shows the fluorescence decay of the A1 fraction for each pixel in 
pseudocolour coding shown in j. (h) A lifetime decay curve in a semi-logarithmic plot, 
which was obtained from eight boutons. The decay fits well with a single exponential 
function with a time constant of 3.5 ns. (i) The residual data after subtracting the 
exponential function. (j) Images of synaptic boutons lipofected with the tandem  
mtq－Venus－SNAP25b probe (scale bar, 5 µm). (k) A lifetime decay curve  
in a semi-logarithmic plot obtained from 13 boutons, which fits well with a 
double-exponential function, with time constants of 0.7 ns (τ1) and 3.5 ns (τ2) and 
weights of 66 % (A1) and 34 % (A2), respectively. (l) The residual data after subtracting 
the A2 component (red) or both components (black). (m) The A1 fractions of  
mtq－SNAP25 (0.28 ± 1.9 %; 19 boutons) and mtq－Venus－SNAP25 probes  (63.5 ± 
1.2 %; 12 boutons). Wilcoxon signed-rank test versus 0 %: P = 0.71 and **P = 0.002, 
respectively. 
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Figure 2｜SNARE Probes for FRET/2pFLIM Analysis Used in the Present Study.   
mtq and Venus  are in blue and yellow, respectively.  
The soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) 
motifs are in black. The lengths of the linker amino acids between the SNARE motives 
are indicated. 
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Figure 3 | FRET/2pFLIM of mtq－Syx in live or after fixation. 
(a,c) Fluorescence and A1 fraction images of mtq－Syx－expressing boutons  
(scale bars, 5 μm). Preparations were live-imaged in a and were imaged after chemical 
ﬁxation and counterstaining with anti-synaptophysin antibody in c. (b,d) Lifetime decay 
curves of mtq－Syx obtained from 14 boutons. 
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Figure 4｜FRET from mtq－Syx to Venus－VAMP2 detected by 2pFLIM.  
(a) Fluorescence and A1 fraction images of mtq－Syx/Venus－VAMP2-stained boutons 
(scale bars, 5 µm). (b) Lifetime decay curves of mtq－Syx/Venus－VAMP2 obtained 
from 12 live boutons. (c) Images of Venus fluorescence and the A1 fraction of  
mtq－Syx before and after photobleaching of Venus in the axonal boutons (scale bar,  
5 µm). (d) The A1 fractions of boutons before photobleaching (31.7 ± 1.9 %,  
20 boutons) for endogenous expression levels of Venus－VAMP2 expression (mean ± 
SD = 712 ± 111 A.U.) and after photobleaching (1.8 ± 1.1 %) of Venus－VAMP2 (mean 
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± SD = 198 ± 22 A.U). **P = 0.0004 with the Mann–Whitney U-test. (e) An image of 
the A1 values of mtq－Syx for mVenus－VAMP2 (scale bar , 5 µm). (f) The A1 values 
obtained by mtq－Syx/mVenus－VAMP2 in bouton (36.3 ± 2.2 %, 12 
boutons:A1bouton) with the expression level of mVenus of 46-185 % endogenous level 
(mean ± SD = 587 ± 69 A.U.) and in axon (19.4 ± 1.5 %, 11 axons : A1axon), which are 
not significantly different from those obtained by mtq－Syx/Venus－VAMP2 (see Fig. 
11c; P = 0.56 and 0.25 in boutons and axons, respectively). 
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Figure 5｜The Dependence of the A1 Fractions on the Expression Levels of FRET 
Acceptors in the Neurons.  
The A1 values for mtq－Syx/Venus－VAMP2 (a,b) plotted against the expression levels 
of mtq－Syx (arbitrary unit) of each probe in each bouton in the absence and presence 
of clostridial toxins. The endogenous expression levels of each SNARE protein, 
obtained from c, d, are indicated with red ovals denoted as ‘Endo.’ (c,d) Fluorescence 
intensities of boutons stained with anti-SNARE antibodies are plotted against the 
fluorescence intensity of the same proteins labelled either with Venus or mtq for 
boutons in rat dissociated culture (n = 69, 51). 
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Figure 6｜Specificity of antibodyes against VAMP2, Syx and SNAP25.  
(a) Images of anti-VAMP2 conjugated with Alexa594, mtq－SNAP25b and their 
overlays in dissociated culture preparations without and with expression of the light 
chain of TeNT (scale bar, 2 µm). (b) Alexa fluorescence intensities conjugated with 
anti-VAMP2 antibody in control (80.3 ± 2.6 A.U., 20 boutons) and in TeNT (11.1 ± 
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0.79 A.U., 20 boutons), with anti-Syx antibody (135.7 ± 3.4 A.U., 20 boutons) and in 
BoNTC1α-51 (10.6 ± 1.1 A.U., 20 boutons), and with anti-SNAP25b (57.0 ± 2.1 
A.U., 20 boutons) and in BoNTE (7.4 ± 1.1 A.U., 20 boutons). **P < 0.001 with the 
Mann–Whitney U-test. 
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Figure 7｜FRET/2pFLIM analysis of homotypic Syx or SNAP25 binding.  
(a) Schematic drawing of mtq－Syx/Venus－Syx. (b) Fluorescence and A1 images of 
mtq－Syx/Venus－Syx-expressing boutons (scale bar, 5 µm). (c,d) The A1 values 
among boutons with various expression levels of Syx and SNAP25. The green shaded 
area was used to obtain the A1 value for the endogenous expression level of the 
acceptor Syx of 154 A.U.: 61 %–145 % (d, mean ± SEM = 148 ± 8 A.U., n = 16).  
(e,f) Fluorescence intensities of boutons stained with anti-SNARE antibodies are plotted 
against the fluorescence intensity of the same proteins labelled either with Venus for 
boutons in rat dissociated culture (e,f; n = 51, 51). (g) Schematic drawing of  
mtq－SNAP25/Venus－SNAP25. (h) Fluorescence and A1 images of  
mtq－SNAP25/Venus－SNAP25-expressing boutons (scale bar, 5 µm). (i,j) The A1 
values among boutons with different expression levels of mtq－SNAP25b (i) or  
Venus－SNAP25b (j). The green shaded area was used to obtain the A1 value for the 
endogenous expression level of the acceptor SNAP25 of 262 A.U.: 53 %–150 %  
(i, mean ± SD = 251 ± 23 A.U., n = 13). (k,l) Fluorescence intensities of boutons stained 
with anti-SNARE antibodies are plotted against the fluorescence intensity of the same 
proteins labelled either with Venus for boutons in rat dissociated culture (e,f; n = 46, 43). 
(m) The A1 values of mtq－Syx/Venus－Syx (1.2 ± 1.4 %, n = 16) and  
mtq－SNAP25b/Venus－SNAP25b (1.4 ± 1.1 %, n = 13) with the endogenous 
expression levels of Syx and SNAP25, respectively (e,f). Wilcoxon signed-rank test 
versus 0 %: P = 0.63 and P = 0.17, respectively. 
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Figure 8 | FRET/2pFLIM of the SNARE complexes between mtq－Syx and Venus
－VAMP2 in neurons.  
(a) Fluorescence and A1 fraction images of mtq－Syx/Venus－VAMP2-expressing 
boutons (scale bars, 5 µm). Preparations were after chemical ﬁxation and 
counterstaining with anti-synaptophysin antibody. (b) Lifetime decay curves of  
mtq－Syx/Venus－VAMP2 obtained from 12 live boutons and 8 ﬁxed boutons. 
(c) The A1 fractions of mtq－Syx (black bar; 0.18 ± 1.4 %; 14 boutons) or after ﬁxation 
(blue bar; 2.4 ± 2.9 %; 14 boutons) and mtq－Syx/Venus－VAMP2 stained boutons in 
live images (black bar; 34.1 ± 2.0 %; 21 boutons) and after ﬁxation (blue bar; 33.2 ± 
1.3 %; 19 boutons) at the endogenous expression level of VAMP2 (Fig. 5d). The A1 
fractions for mtq－Syx/Venus－VAMP2 were signiﬁcantly different from 0 % (**P = 
0.0004 and **P = 0.0001 using the Wilcoxon signed-rank test). The A1 fraction was not 
affected by ﬁxation (P = 0.74 using the Mann–Whitney U-test). (d) Distributions of the 
A1 fractions in the boutons among the pixels positive (red; 38.8 ± 1.8 %; 519 pixels) or 
negative (blue; 17.4 ± 2.2 %; 323 pixels) for anti-synaptophysin staining or in axons 
(black; 15.6 ± 2 %; 183 pixels; P=0.0002 using the Kruskal–Wallis test; P = 0.75 and 
††P = 0.0039 for boutons negative and positive for synaptophysin versus axons using 
Steel’s test). 
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Figure 9 FRET/2pFLIM of cis-SNARE complexes between Syx－mtq and VAMP2
－Ven in neurons.   
(a) Schematic drawing of the conformation change of the cis-probes via exocytosis.  
(b) Fluorescence and A1 fraction images of Syx－mtq/VAMP2－Venus-expressing 
boutons (scale bar, 5 µm). (c,d) The A1 values for Syx－mtq/VAMP2－Venus plotted 
against the expression levels of Syx－mtq and VAMP2－Venus (arbitrary unit) of each 
probe in each bouton in the absence and presence of BoNTE. The endogenous 
expression levels of each SNARE protein, obtained from (e,f) are indicated with red 
ovals denoted as ‘Endo.’. (e,f) Fluorescence intensities of boutons stained with 
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anti-SNARE antibodies are plotted against the fluorescence intensity of the same 
proteins labelled either with Venus or mtq for boutons in rat dissociated culture. (g) The 
average A1 fractions of Syx－mtq/VAMP2－Venus-stained boutons (black) and axons 
(open) in the absence and presence of the light chain of botulinum toxin (BoNTE). The 
A1 fractions in boutons (24.7 ± 2.1 %; 24 boutons) and axons (21.5 ± 2.0 %; 19 axons) 
were significantly different from 0 % (**P = 0.0001 and 0.00001 using the Wilcoxon 
signed-rank test) in the absence of BoNTE at the mean expression levels of  
VAMP2―Ven of 524 ± 45 A.U. and 508 ± 26 A.U., respectively (Fig. 9d). They were 
not significantly different from 0 % in the boutons (3.5 ± 2.1 %; 22 boutons) and axons 
(0.9 ± 2 %; 12 axons) in the presence of BoNTE using the Wilcoxon signed-rank test  
(P = 0.12 and 0.53). The Mann–Whitney U-test yielded ††P = 0.00001 for boutons 
without and with toxin, and ††P = 0.00001 for axons. (h) The correlation between the A1 
fractions in the boutons (A1bouton) and those of axons surrounding the boutons 
(A1axon; P = 0.0001 using Spearman’s rank correlation coefficient; r = 0.80; n = 27). 
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Figure 10. Sucrose stimulation of preparations staning with the cis-probe in the 
absence and presence of BoNTE.  
(a) Schematic illustaration of the action of BoNTE on exocytosis.  
(b) Fluorescence and A1 fraction images of boutons expressing Syx－mtq, 
VAMP2－Venus and BoNTE (scale bar, 5 µm). (c) Fluorescence lifetime images of  
Syx－mtq/VAMP2－Venus-stained boutons during 300 mM sucrose stimulation  
(scale bar, 1 µm). (d) The time courses of the A1 fractions estimated either by decay 
curve fitting (filled circles, 21 boutons) or average lifetimes (open symbols, 21 boutons) 
in the boutons (TA1bouton, open circles, n = 19) and axons surrounding the boutons 
(TA1axon, open triangles). All values after sucrose stimulation were significantly  
(P < 0.01) different from those before stimulation. (e) The time courses of A1bouton 
estimated by average lifetimes during 300 mM sucrose stimulation in the preparation 
treated with BoNTE (n = 19).  
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Figure 11 | Action of the light chain of botulinum toxin E (BoNTE) on the SNARE 
complexes.  
(a) Schematic drawing of the trans-complex with mtq－Syx/Venus－VAMP2 and the 
site of action of the light chain of BoNTE, which blocks exocytosis and the formation of 
the cis-complex. (b) Fluorescence and A1 fraction images of boutons simultaneously 
lipofected with mtq－Syx, Venus－VAMP2 and BoNTE (scale bar, 5 µm). (c) The A1 
fractions of boutons in the absence and presence of BoNTE (16.3 ± 1.6 %, 39 boutons) 
at the endogenous expression level of VAMP2 (Fig. 5b) and of axons in the absence 
(open bars, 22.4 ± 0.9 %; 33 axons) and in the presence of BoNTE (-1.9 ± 1.8 %;  
17 axons). Wilcoxon signed-rank test versus 0 %: **P = 0.0001 in BoNTE-treated 
boutons, whereas **P = 0.0003 and P = 0.42 in axons untreated or treated with BoNTE.  
The A1 fraction values of BoNTE versus control in boutons and axons differed with  
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††P = 0.0006 and ††P = 0.004 using the Mann–Whitney U-test, respectively. 
(d) The correlation between the A1 fractions of individual boutons (A1bouton) and 
those in the surrounding axons (A1axon; P = 0.0012 using Spearman’s rank correlation 
coefﬁcient; r = 0.59; n = 36). (e) The correlation between (A1bouton–A1axon) and 
A1axon (P = 0.21 using Spearman’s rank correlation coefﬁcient; r = -0.23, n = 36).  
(f) The correlation between (A1bouton–A1axon) and the bouton area in its central 
Z-section (P = 0.20 using Spearman’s rank correlation coefﬁcient; r = 0.13, n = 32). 
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Figure 12｜TTX effects on the A1 fractions for mtq－Syx/Venus－VAMP2.  
(a) The A1 fractions (34.5 ± 1.8 %, 16 boutons; 18.9 ± 1.8 %, 21 axons) in control, and 
those (20.9 efﬁci %, 21 boutons; 6.1 ± 3.0 %, 12 axons) 1 h after treatment of TTX, and 
those (16.9 ± 1.4 %, 23 boutons; 3.6 ± 0.9 %, 10 axons) 4 h after treatment of TTX. 
** P < 0.001 with the Mann–Whitney U-test vs. 0 h. (b) The trans-SNARE fractions 
obtained by the gradient method in control (16.0 ± 1.2 %, 15 boutons), 1 h after TTX 
treatment (16.0 ± 4.2 %, 11 boutons) and 4 h after (14.1 ± 1.9 %, 10 boutons). 
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Figure 13 | FRET/2pFLIM of mtq－SNAP25-based probes for SNARE complexes. 
(a) Schematic drawing of mtq－SNAP25/Venus－VAMP2 probes. (b) Fluorescence and 
A1 fraction images of mtq－SNAP25/Venus－VAMP2 expressing boutons (scale bars, 
5 µm). (c,d) The A1 values for mtq－SNAP25/Venus－VAMP2 plotted against the 
expression levels of mtq－SNAP25 (c) and Venus－VAMP2 (d) (arbitrary unit) in the 
absence and presence of BoNTC1α-51. (e) The A1 fractions of mtq－SNAP25/ 
Venus－VAMP2-expressing boutons (ﬁlled; 36.7 ± 2.2 %; 20 boutons at the 
endogenous expression level of VAMP2; Fig. 5d) and axons (open; 22.7 ± 1.3 %;  
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22 axons) and those in the presence of BoNTC1α-51 in boutons (14.5 ± 2.2 %;  
24 boutons) and in axons (-0.4 ± 1.1 %; 17 axons). **P＜0.001 for control boutons and 
axons and **P = 0.0001 for BoNTC1α-51-treated boutons using the Wilcoxon 
signed-rank test versus 0 %. Using the Kruskal–Wallis test on the four groups,  
I obtained a P value of ＜0.00001, and the effects of BoNTC1α-51 on boutons and 
axons were †P = 0.03 and †P = 0.04, respectively, using Scheffé’s test. ††P = 0.004 
between control boutons and axons and ††P = 0.002 between BoNTC1α-51-treated 
boutons and axons. (f) Schematic drawing of mtq－SNAP25/Venus－VAMP2 probes 
and the action of BoNTC1α-51.  
(g) Fluorescence and A1 fraction images of mtq－SNAP25/Venus－VAMP2-expressing 
boutons in the absence (g) and presence of tetanus toxin (BoNTC1α-51) (scale bars,  
5 µm).  
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Figure 14 | FRET/2pFLIM of mtq－SNAP25-based probes for SNARE complexes. 
(a) Schematic drawing of mtq－SNAP25/Venus－Syx probe. (b) Fluorescence and A1 
fraction images of mtq－SNAP25/Venus－Syx expressing boutons (scale bars, 5 µm). 
(c,d) The A1 values for mtq－SNAP25/Venus－Syx plotted against the expression 
levels of mtq－SNAP25 (c) and Venus－Syx (d) (arbitrary unit) in the absence and 
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presence of TeNT. (e) The average A1 fractions of mtq－SNAP25/Venus－Syx-stained 
boutons (ﬁlled; 29.5 ± 3.1 %; 21 boutons with the mean expression of Venus－Syx of 
139 A.U.; Fig. 7f) and axons (open; 16.2 ± 1.3 %; 28 axons), those of boutons in the 
presence of TeNT (12.0 ± 1.1 %; 45 boutons with the mean expression level  
Venus－Syx of 138 A.U.) and of axons (2.4 ± 1.7 %; 15 axons). **P ＜ 0.01 for 
control boutons, axons and TeNT-treated boutons using the Wilcoxon signed-rank test 
versus 0 %. Using the Kruskal–Wallis test on the four groups, I obtained a P value of 
＜ 0.00001. The A1 values of boutons and axons were different (††P = 0.004) in the 
absence of the toxin, and the toxin’s effects were signiﬁcant: ††P = 0.0007 and †P = 0.04 
for boutons and axons using Scheffé’s test. (f) Schematic drawing of the action of TeNT 
on mtq－SNAP25/Venus－Syx probe. (g) Fluorescence and A1 fraction images of  
mtq－SNAP25/Venus－Syx expressing boutons (scale bars, 5 µm). 
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Figure 15 | Kinetics of EPSCs, depletion and reﬁlling of vesicles mediated by  
mtq－SNAP25b/Venus－VAMP2 in SNAP25 KO mice treated with TeNT.  
(a,b) EPSCs recorded from dissociated cultures from wild-type (WT) mice after the ﬁrst 
stimulation (a) and during 20 repetitive stimuli at 20 Hz in the presence of picrotoxin 
(50 µM) and cyclothiazide (100 µM). The current traces were recorded with whole-cell 
patch clamp, and presynaptic ﬁbres were stimulated with a glass electrode. (c,d) EPSCs 
evoked from the same cell by the second repetitive stimulation 1 s after the ﬁrst train of 
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stimuli. (e) Amplitudes of the ﬁrst EPSCs in the repetitive stimulation relative to that of 
the ﬁrst train of stimulation. Two trains were separated by 1s in the preparations from 
WT mice (ﬁlled circles, 40 ± 21 %, n = 6, P = 0.04), those from the KO mice rescued 
with mtq－SNAP25b (grey circles, 29 ± 8.5 %, n = 5, P = 0.043), and those from the 
KO mice expressing mtq－SNAP25b and Venus－VAMP2 (TeNT resistant) after 
treatment with TeNT (open circles, 39 ± 12 %, n = 8, P = 0.01). The P values were 
obtained with the Wilcoxon signed-rank test. The amplitudes recovered to 91 ± 16 %  
(n = 6, P = 0.6), 96 ± 13 % (n = 4, P = 0.1), and 125 ± 13 % (n = 4, P = 0.9) when the 
interval was set to 10 s. (f,g) EPSCs evoked by the ﬁrst (f) and second (g) repetitive 
stimulation separated by 10 s. (h―m) EPSCs recorded from dissociated cultures 
obtained from SNAP25 KO mice (h,i), those rescued by mtq－SNAP25b (n = 8) (j,k) 
and those with exocytosis blocked by TeNT treatment (n = 8) (l,m). (n―q) Current 
traces recorded from dissociated culture preparations from SNAP25 KO mice 
expressing mtq－SNAP25 and Venus－VAMP2(TeNTR), and treated with TeNT  
for 1 day. The ﬁrst and second repetitive stimuli were separated by 1 s. 
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Figure 16 | FRET/FLIM images of mtq－SNAP25b/Venus－VAMP2 in SNAP25 
KO mice treated with TeNT.  
(a) Fluorescence and A1 images of mtq－Syx/Venus－VAMP2(TeNTR)-expressing 
boutons (scale bar, 1 µm). (b) The mean A1 values in boutons (24.4 ± 1.6 %, n = 23) 
and axons (13.1 ± 0.7 %, n = 35). A Mann–Whitney U-test yielded a **P value of 
0.0000. The average expression levels of mtq－SNAP25 and Venus－VAMP2(TeNTR) 
were 79 ± 6.7 A.U. and 541 ± 39 A.U., respectively. 
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Figure 17｜Lifetime decay curves in boutons of CA1 pyramidal neurons in 
hippocampal slice cultures.   
Slice preparations were transfected with mtq2－Syx (a); mtq2－Syx/Venus－VAMP2 
(b); Syx－mtq2/VAMP2－Venus (c) expressed using AAV1/2 virus-mediated gene 
transfer into the CA3 region, and lifetime decay were analyzed as in Fig. 3b and Fig. 4b. 
The fluorescence data were accumulated from 8, 38, and 24 boutons. τ2 was set as 3.8 
ns in (a), (b), and (c). 
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Figure 18 | FRET/2pFLIM of presynaptic boutons on the dendritic spines of CA1 
pyramidal neurons in slice culture preparations.  
(a) Schematic drawing of Schaffer collateral ﬁbres on CA1 pyramidal neurons in the 
stratum radiatum. (b) Schematic drawing of cis-SNARE probes, Syx－mtq2 and 
VAMP2－Venus, which induce FRET after exocytosis. (c) Fluorescence lifetime images 
of Syx－mtq2/VAMP2－Venus-stained boutons during 300 mM sucrose stimulation 
(scale bar, 1 µm). (d) Average time courses of the A1 fraction in boutons during sucrose 
application (24 boutons, 8 axons). (e) The correlation between the A1 fractions in the 
boutons (A1bouton) and those of axons surrounding the boutons (A1axon; P ＜ 0.0001 
in Spearman’s rank correlation coefﬁcient; r = 0.74; n = 59). (f) Schematic drawing of 
the SNARE probes mtq2－Syx and Venus－VAMP2 in the trans-complex. (g,h) 
Fluorescence images (Z-stacks of three sections) of a Schaffer collateral axon 
expressing mtq2－Syx (g) and Venus－VAMP2, which were transfected into CA3 
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neurons using an AAV1, and of dendritic spines expressing mCherry (h) expressed by 
gene gun (scale bar, 1 µm). These images were simultaneously acquired with the same 
excitation laser at 900 nm. (i) The overlap of a bouton (g) and spine (h) in both  
the xy plane (upper panel) and xz plane along the yellow line (lower panel).  
(j) A lifetime image of mtq2 obtained from the image (g), which shows a high FRET 
region at the edge of the axonal bouton facing the spine in both xy and xz images.  
(k) A ﬂuorescence image of Venus－VAMP2 obtained from the same area at 980nm, 
where the precise location of Venus－VAMP2 relative to the dendrite was aligned by 
simultaneous imaging of Venus－VAMP2 and mCherry. (l) The ﬂuorescence proﬁles 
along the yellow line in i for mtq2－Syx, Venus－VAMP2, mCherry and A1-A1axon 
fractions of mtq lifetime images. The cyan-shaded region represents the axonal area 
where the ﬂuorescent intensity of mtq－Syx was 50 % of the peak value.  
(m) The correlation between spine volume (VH) and A1bouton-A1axon. Spearman’s 
rank correlation coefﬁcients were r = 0.59 (P = 0.008, n = 19). (n) The correlation 
between spine volume (VH) and the peak A1bouton value at the point facing the spine 
(A1s-A1axon, n). In addition to the data points in (m), I intentionally sampled more 
spines from larger spines. Spearman’s rank correlations was 0.45 (P = 0.0095, n = 32, 
the red dashed line) for spines with volumes ＜ 0.2 µm2, while -0.067 (P = 0.86, n = 
18, the blue horizontal dashed line) for spines with volume ＞ 0.2 µm2. The average 
A1s–A1axon values for spines with volumes ＞ 0.25 µm2 was 27.7 ± 2.1 % (n = 16). 
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Figure 19｜Ca2+ transients in dendritic spines of CA1 pyramidal neurons evoked 
by electrical stimulation of presynaptic fibers in hippocampal slice cultures.   
(a,c) Images of spines (single Z-section) from which Ca2+ imaging was performed with 
GCaMP6s during repetitive presynaptic stimulation, as indicated in the right panels 
(scale bars, 1 µm). (b,d) Amplitude histograms of evoked Ca2+ responses. The red lines 
indicate the threshold Ca2+ responses for successful release events, which are defined as 
100 % increases in GCaMP signals above three times the standard deviation of the 
baseline noise. (e) Probability of success rate plotted against spine volume (P = 0.0062 
using Spearman’s rank correlation coefficient; r = 0.73; n = 25). 
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Figure 20 | FRET/2pFLIM with SNARE probes in the β cells in the pancreatic 
islets of Langerhans.  
(a) A ﬂuorescence image of islets transfected with mtq－SNAP25 by lentivirus (scale 
bar, 50 µm). The arrow indicates the typical cells investigated. (b) Schematic drawings 
of three FRET probes. (c,d,g,h,j,k) Fluorescence and A1 fraction images of  
mtq－SNAP25/Venus－Syx (c,d), mtq－Syx/Venus－VAMP2 (g,h) or mtq－SNAP25 
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and Venus－VAMP2 (j,k) (scale bars, 5 µm). ‘G’ denotes the Golgi apparatus, and ‘M’ 
in the right panels of images (d,h,k) denotes the masked cytosolic regions. (e,i,l) 
Lifetime decay curves of the plasma membranes of β cells transfected with  
mtq－SNAP25/Venus－Syx (b, e), mtq－Syx/Venus－VAMP2 (b, i), and  
mtq－SNAP25 and Venus－VAMP2 (b, l), which were obtained from 12, 12 and 11 
cells, respectively. (f) The average A1 fractions of the lifetime decay of β cell plasma 
membrane transfected with four different probes indicated. The A1 fractions of  
mtq－SNAP25 are -0.8 ± 1.1 % (10 cells; P = 0.14), those mtq－SNAP25/Venus－Syx 
are 5.3 ± 1 % (22 cells; **P ＜ 0.01), those of mtq－Syx/Venus－VAMP2 are  
0.8 ± 2.3 % (15 cells; P = 0.82) and those of mtq－SNAP25/Venus－VAMP2 are  
0.04 ± 1.4 % (21 cells; P = 0.89) at the endogenous expression levels of Venus－Syx 
and Venus－VAMP2 (Fig. 21d,f ;see Fig.22), respectively. The P values were obtained 
using the Wilcoxon signed-rank test. The four groups were signiﬁcant in analysis using 
the Kruskal–Wallis test with P ＜ 0.007. Steel’s test versus mtq－SNAP25 yielded  
P = 0.014 for mtq－SNAP25/Venus－Syx, P = 0.92 for mtq－Syx/Venus－VAMP2 and 
P = 0.74 for mtq－SNAP25/Venus－VAMP2. 
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Figure 21｜The Dependence of the A1 Values on the Expression Levels of the 
Acceptors in β cells in the Pancreatic Islets.  
The A1 values for mtq－SNAP25/ Venus－Syx (a,b), The A1 values are estimated from 
the data using the expression levels of the donor indicated by green shaded areas: 
66 %–205 % (b, 114 ± 9 A.U., n = 22). The solid lines are horizontal in (a), and through 
the origin with the least square fits of the data (b). The correlation coefficients were 
−0.1 for 68  islet cells, respectively, and the P value was 0.001 in (a), using 
Spearman’s rank correlation coefficient. In contrast, the A1 values were more correlated 
with acceptor expression, particularly in (b). The correlation coefficient was 0.74 for 68 
islet cells, and the P value was 0.0001 for (b). mtq－SNAP25/Venus－Syx (c,d) and 
mtq－Syx/Venus－VAMP2 (e,f) plotted against the expression levels of three SNAREs 
measured by fluorescence intensity of each probe in the region of interest encompassing 
the plasma membrane in arbitrary unit. The endogenous expression levels of each 
SNARE protein, 92 A.U.  for SNAP25 (mtq), 97 A.U. for Syx (Venus), 10 A.U. for Syx 
(mtq) and 130 A.U. for VAMP2 (Venus). (c―f)Fluorescence intensities of β cell 
plasma membrane stained with anti-SNARE antibodies are plotted against the 
fluorescence intensity of the same proteins labelled with mtq or Venus in β cells 
in the islets of Langerhans (n = 35, 44, 37, 55). 
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Figure 22｜The Dependence of the A1 Values on the Expression Levels of the 
Acceptors in β cells in the Pancreatic Islets.   
The A1 values for mtq－SNAP25/Venus－VAMP2 (a,b) and mtq－Syx/Venus－
VAMP2 (c,d) plotted against the expression levels of three SNAREs measured by 
fluorescence intensity of each probe in the region of interest encompassing the plasma 
membrane in arbitrary unit. The A1 values are estimated from the data using the 
expression levels of the acceptor indicated by green shaded areas: 52–145 % (f, 138 ± 
8A.U., n = 21) and 49 %–176 % (d, 139 ± 15 A.U., n = 15) . The solid lines are 
horizontal in (a, c), and through the origin with the least square fits of the data (b, d). 
The correlation coefficients were 0.75 and 0.15 for 39 and 29 islet cells, respectively, 
and the P values were 0.0001 and 0.75 in (a) and (c), respectively, using Spearman’s 
rank correlation coefficient. In contrast, the A1 values were more correlated with 
acceptor expression, particularly in (b). The correlation coefficients were 0.5 and 0.21 
for 39 and 29 islet cells, respectively, and the P values were 0.0002 and 0.28 for (b) and 
(d) , respectively. 
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Figure 23 | Increases in FRET signals between SNARE probes by individual 
exocytosis of insulin vesicles.  
(a) Fluorescence images of a pancreatic islet immersed in an Alexa594 solution, where 
arrowheads indicate an individual exocytotic event (scale bar, 1 µm). The islet was 
transfected with mtq－SNAP25 and Venus－VAMP2 using a lentivirus, and stimulated 
with a high-glucose (16 mM) solution. (b) Increases in Alexa594 ﬂuorescence by 
exocytosis of a single insulin vesicle. (c－e) Increases in the binding fraction of mtq－
SNAP25 and Venus－VAMP2 during individual exocytotic events. (f) Average time 
course of the binding fraction from 61 exocytotic events that were aligned to the onset 
of the Alexa594 signal (b). (g) A1 images before (f1 and f2) and after exocytosis (f3) 
(scale bar, 1 µm). (h,i) Schematic illustration of the formation of SNARE complexes 
and exocytosis in β cells (h) and presynaptic bouton (i). 
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Table  1 
Preparations Methods trans-SNARE fractions 
Dissociated 
culture 
“Subtraction Method” Mean ± SEM 
  Syx/VAMP2 in axons 0.9 % ± 2.2 % 
   Syx/VAMP2 in boutons 9.4 % ± 3.6 % 
 “Gradient Method” in boutons  
  Syx/VAMP2 11.7 % ± 3.0 % 
  SNAP25/VAMP2 14.0 % ± 2.5 % 
  SNAP25/VAMP2 in KO mice 11.3 % ± 1.7 % 
  SNAP25/Syx 13.3 % ± 3.4 % 
  Syx/VAMP2 in AZ 24.2 % ± 2.7 % 
Slice culture “Gradient Method” in boutons  
   Syx/VAMP2  11.9 % ± 10.2 % 
   Syx/VAMP2 in AZ 27.7 % ± 2.1 % 
Pancreatic islet  
β cells 
Total SNARE complexes in the 
plasma membrane 
 
   Syx/VAMP2 0.8 % ± 2.3 % 
   SNAP25/VAMP2 0.04 % ± 1.4 % 
Table 1｜Estimated fractions of trans-SNARE complexes in Syx or SNAP25.  
Three different preparations, cortical neurons in dissociated culture, hippocampal 
pyramidal neurons in slice cultures and β cells in the islets of Langerhans. al neurons n 
method” utilized the FRET values estimated from the total SNARE assembly minus 
cis-SNARE assembly using Syx/VAMP2 (Fig. 3,9 and 11). “Gradient method” can be 
applied to all three pairs of SNAREs, and the fractions in the axons were subtracted 
from those in the boutons (Fig. 9―14). Trans-SNARE in the active zone was estimated 
using the peak A1 values in dissociated culture (Fig. 8d), and those of presynaptic 
boutons facing the spine with volume larger than 0.25 µm3 (Fig. 18n). The total binary 
SNARE complexes were estimated in the plasma membranes of β cells (Fig. 20). 
